相关实验视频

Updated: Jul 9, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

一种蛋白质结合剂的新型设计,用于对抗Staphylococcus enterotoxin B

Ke Ming¹, Banbin Xing², Yang Hu²

¹School of life sciences, Hubei University, Wuhan, Hubei, PR China; State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China; Hubei Jiangxia Laboratory, Wuhan, Hubei, PR China.

International journal of biological macromolecules

|December 9, 2023

概括

研究人员设计了一种新型蛋白质结合剂,以阻止葡萄球菌肠毒素B (SEB) 与MHC-II分子的相互作用. 这种治疗方法在体外成功抑制了SEB诱导的炎症,为SEB相关疾病提供了潜在的治疗方法.

科学领域:

免疫学免疫学免疫学
计算生物学计算生物学
蛋白质工程是指蛋白质工程.

背景情况:

葡萄球菌肠毒素B (SEB) 通过与MHC-II分子结合并过度激活免疫细胞,引发严重的炎症.
开发抑制剂来破坏SEB-MHC-II相互作用对于减轻SEB致命影响至关重要.

研究的目的:

通过计算设计新的蛋白质结合剂,以SEB的MHC-II结合域为目标.
优化粘合剂的性能,以提高对SEB的稳定性和有效性.

主要方法:

采用了新的计算设计方法来识别SEB准绑定因素.
使用ProteinMPNN工具优化了粘合剂的疏水相互作用和复杂稳定性.
进行了体外测试,以评估结合剂在抑制SEB诱导的炎症反应中的有效性.

主要成果:

设计了一种原始的56氨基酸蛋白质结合剂,具有三螺旋捆绑结构.
计算优化增强了粘合剂-SEB复合物的疏水界面和稳定性.
优化的结合剂在体外显著抑制了SEB诱导的炎症.

结论:

这项研究验证了一种新的计算方法,用于设计针对SEB的蛋白质结合剂.
开发的结合剂显示出作为SEB引起的疾病的潜在治疗剂的希望.

关键词:

蛋白质结合剂是一种蛋白质结合剂.蛋白质 de novo 设计葡萄球菌肠道毒素B

更多相关视频

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

Published on: February 1, 2018

Biomimetic Materials to Characterize Bacteria-host Interactions

Biomimetic Materials to Characterize Bacteria-host Interactions

Published on: November 16, 2015

相关概念视频

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...